Skip to content

OnKure Therapeutics, Inc. OKUR Market capitalization

Market capitalization at other companies

Pfizer logo
PfizerPFE
$159.73B+11.1%
Inhibrx Biosciences, Inc. logo
Inhibrx Biosciences, Inc.INBX
$982.03M+385%
Replimune Group logo
Replimune GroupREPL
$762.47M-18.2%
IDEAYA Biosciences, Inc. logo
IDEAYA Biosciences, Inc.IDYA
$2.93B+104%
Erasca, Inc. logo
Erasca, Inc.ERAS
$5.03B+1,196%
Arcus Biosciences logo
Arcus BiosciencesRCUS
$2.71B+226%

Other financials

Income statement

See full
Revenue-
Operating income-$15.6M+8.1%
Net income-$15.2M+4.8%
EPS (diluted)-$1.11+6.7%

Balance sheet

See full
Cash & equivalents$192.1M+98.7%
Total debt$409.0K-57.2%
Total equity$184.4M+103%
Total assets$198.7M+98.9%

Cash flow

See full
Operating cash flow-$12.9M+7.6%
CapEx$5.0K-72.2%
Free cash flow-$12.9M+7.7%

Valuation

See full
Enterprise value-$7.49M-127%

Returns & leverage

See full
Return on equity-42.7%
Debt / equity0.0×
Current ratio13.8×+2.6×

Where this comes from

Computed from the period-end share price: $178.25M.

The official record: OnKure Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about OnKure Therapeutics, Inc.'s market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is OnKure Therapeutics, Inc.'s market capitalization?
OnKure Therapeutics, Inc. (OKUR) reported market capitalization of $178.25M in Q1 2026.
How has OnKure Therapeutics, Inc.'s market capitalization changed year-over-year?
OnKure Therapeutics, Inc.'s market capitalization decreased by 2.0% year-over-year, from $181.92M to $178.25M.
What does market capitalization mean?
The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.